《超药品说明书用药目录(2022年版)》发布,新增37条用药信息

2022-06-30 网络 网络

6月28日,广东省药学会更新发布了《超药品说明书用药目录(2022年版)》,新增37条超说明书用药信息,这是2015年以来发布的第8版。

6月28日,广东省药学会更新发布了《超药品说明书用药目录(2022年版)》,新增37条超说明书用药信息,这是2015年以来发布的第8版。除广东地区外,本版目录起草单位包括北京、辽宁、黑龙江、上海、江苏、浙江、安徽、湖北、湖南、海南、重庆、四川、陕西、福建等省、市的三甲医院。

 

超药品说明书又称“药品说明书外法”、“药品未注册法”,是指药品使⽤的适应证、剂量、疗程、途径或⼈群等未在药品监督管理部门批准的药品说明书记载范围内的法。

 

新增37条用药信息

 
下载地址:
http://sinopharmacy.com.cn/notification/2497.html

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2042370, encodeId=73f120423e04d, content=<a href='/topic/show?id=1e5d9292245' target=_blank style='color:#2F92EE;'>#超药品说明书用药目录#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92922, encryptionId=1e5d9292245, topicName=超药品说明书用药目录)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e2c339, createdName=by2009, createdTime=Sun Dec 18 13:39:29 CST 2022, time=2022-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716468, encodeId=07221e1646893, content=<a href='/topic/show?id=edea92920f3' target=_blank style='color:#2F92EE;'>#超药品说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92920, encryptionId=edea92920f3, topicName=超药品说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5732222237, createdName=jklm20, createdTime=Mon Mar 20 14:39:29 CST 2023, time=2023-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230604, encodeId=95ff1230604ce, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74e06497418, createdName=ms1000001784410327, createdTime=Tue Jul 05 00:23:50 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507227, encodeId=f4db150e22789, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Sat Jul 02 08:39:29 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628854, encodeId=2a8d1628854cc, content=<a href='/topic/show?id=57c38e486a2' target=_blank style='color:#2F92EE;'>#药品说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87486, encryptionId=57c38e486a2, topicName=药品说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd8c21208991, createdName=fanweitanzhen, createdTime=Sat Jul 02 08:39:29 CST 2022, time=2022-07-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2042370, encodeId=73f120423e04d, content=<a href='/topic/show?id=1e5d9292245' target=_blank style='color:#2F92EE;'>#超药品说明书用药目录#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92922, encryptionId=1e5d9292245, topicName=超药品说明书用药目录)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e2c339, createdName=by2009, createdTime=Sun Dec 18 13:39:29 CST 2022, time=2022-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716468, encodeId=07221e1646893, content=<a href='/topic/show?id=edea92920f3' target=_blank style='color:#2F92EE;'>#超药品说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92920, encryptionId=edea92920f3, topicName=超药品说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5732222237, createdName=jklm20, createdTime=Mon Mar 20 14:39:29 CST 2023, time=2023-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230604, encodeId=95ff1230604ce, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74e06497418, createdName=ms1000001784410327, createdTime=Tue Jul 05 00:23:50 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507227, encodeId=f4db150e22789, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Sat Jul 02 08:39:29 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628854, encodeId=2a8d1628854cc, content=<a href='/topic/show?id=57c38e486a2' target=_blank style='color:#2F92EE;'>#药品说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87486, encryptionId=57c38e486a2, topicName=药品说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd8c21208991, createdName=fanweitanzhen, createdTime=Sat Jul 02 08:39:29 CST 2022, time=2022-07-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2042370, encodeId=73f120423e04d, content=<a href='/topic/show?id=1e5d9292245' target=_blank style='color:#2F92EE;'>#超药品说明书用药目录#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92922, encryptionId=1e5d9292245, topicName=超药品说明书用药目录)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e2c339, createdName=by2009, createdTime=Sun Dec 18 13:39:29 CST 2022, time=2022-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716468, encodeId=07221e1646893, content=<a href='/topic/show?id=edea92920f3' target=_blank style='color:#2F92EE;'>#超药品说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92920, encryptionId=edea92920f3, topicName=超药品说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5732222237, createdName=jklm20, createdTime=Mon Mar 20 14:39:29 CST 2023, time=2023-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230604, encodeId=95ff1230604ce, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74e06497418, createdName=ms1000001784410327, createdTime=Tue Jul 05 00:23:50 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507227, encodeId=f4db150e22789, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Sat Jul 02 08:39:29 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628854, encodeId=2a8d1628854cc, content=<a href='/topic/show?id=57c38e486a2' target=_blank style='color:#2F92EE;'>#药品说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87486, encryptionId=57c38e486a2, topicName=药品说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd8c21208991, createdName=fanweitanzhen, createdTime=Sat Jul 02 08:39:29 CST 2022, time=2022-07-02, status=1, ipAttribution=)]
    2022-07-05 ms1000001784410327

    谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2042370, encodeId=73f120423e04d, content=<a href='/topic/show?id=1e5d9292245' target=_blank style='color:#2F92EE;'>#超药品说明书用药目录#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92922, encryptionId=1e5d9292245, topicName=超药品说明书用药目录)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e2c339, createdName=by2009, createdTime=Sun Dec 18 13:39:29 CST 2022, time=2022-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716468, encodeId=07221e1646893, content=<a href='/topic/show?id=edea92920f3' target=_blank style='color:#2F92EE;'>#超药品说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92920, encryptionId=edea92920f3, topicName=超药品说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5732222237, createdName=jklm20, createdTime=Mon Mar 20 14:39:29 CST 2023, time=2023-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230604, encodeId=95ff1230604ce, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74e06497418, createdName=ms1000001784410327, createdTime=Tue Jul 05 00:23:50 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507227, encodeId=f4db150e22789, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Sat Jul 02 08:39:29 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628854, encodeId=2a8d1628854cc, content=<a href='/topic/show?id=57c38e486a2' target=_blank style='color:#2F92EE;'>#药品说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87486, encryptionId=57c38e486a2, topicName=药品说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd8c21208991, createdName=fanweitanzhen, createdTime=Sat Jul 02 08:39:29 CST 2022, time=2022-07-02, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2042370, encodeId=73f120423e04d, content=<a href='/topic/show?id=1e5d9292245' target=_blank style='color:#2F92EE;'>#超药品说明书用药目录#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92922, encryptionId=1e5d9292245, topicName=超药品说明书用药目录)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e2c339, createdName=by2009, createdTime=Sun Dec 18 13:39:29 CST 2022, time=2022-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716468, encodeId=07221e1646893, content=<a href='/topic/show?id=edea92920f3' target=_blank style='color:#2F92EE;'>#超药品说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92920, encryptionId=edea92920f3, topicName=超药品说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5732222237, createdName=jklm20, createdTime=Mon Mar 20 14:39:29 CST 2023, time=2023-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230604, encodeId=95ff1230604ce, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74e06497418, createdName=ms1000001784410327, createdTime=Tue Jul 05 00:23:50 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507227, encodeId=f4db150e22789, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Sat Jul 02 08:39:29 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628854, encodeId=2a8d1628854cc, content=<a href='/topic/show?id=57c38e486a2' target=_blank style='color:#2F92EE;'>#药品说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87486, encryptionId=57c38e486a2, topicName=药品说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd8c21208991, createdName=fanweitanzhen, createdTime=Sat Jul 02 08:39:29 CST 2022, time=2022-07-02, status=1, ipAttribution=)]

相关资讯

超药品说明书用药目录(2018年版)

5月18日,广东省药学会的官网发布了“关于印发《超药品说明书用药目录(2018年版)》的通知”。通知提到,为了更好地协助各医疗机构制定超说明书用药目录,广东省药学会循证药学专家委员会《超药品说明书用药目录》工作组组织编写了《超药品说明书用药目录(2018年版)》,共收入了98种,共计184个可超说明书使用的药品。